Annovis Bio, Inc. (ANVS)
Data as of , from SEC Form 4 filings.
See up to 3 months of ANVS. The 7-day demo opens the 1M and 3M ranges and puts ANVS on your watchlist.
Start 7-day demoLatest ANVS insider trades
About Annovis Bio, Inc. (ANVS)
Annovis Bio, Inc. is an SEC registrant, filing under CIK 0001477845, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
ANVS Form 4 activity by transaction type, last 90 days
No Form 4 activity for ANVS in the last 90 days.
ANVS insider transactions (Form 4)
2512 Form 4 filings on record, the earliest from May 29, 2025, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Michael B. Hoffman - Director | Open-market purchase | Common Stock | 2,562 | $1.75 | $4K | |
| Michael B. Hoffman - Director | Open-market purchase | Common Stock | 18,849 | $1.80 | $34K | |
| Michael B. Hoffman - Director | Open-market purchase | Common Stock | 54,933 | $1.90 | $104K | |
| Michael B. Hoffman - Director | Open-market purchase | Common Stock | 713,800 | $2.10 | $1.50M | |
| Michael B. Hoffman - Director | Open-market purchase | Common Stock | 1,489 | $4.13 | $6K | |
| Michael B. Hoffman - Director | Open-market purchase | Common Stock | 9,200 | $3.85 | $35K | |
| Michael B. Hoffman - Director | Open-market purchase | Common Stock | 415 | $4.14 | $2K | |
| Michael B. Hoffman - Director | Open-market purchase | Common Stock | 28,096 | $4.15 | $117K | |
| Michael B. Hoffman - Director | Open-market purchase | Common Stock | 10,000 | $3.49 | $35K | |
| Michael B. Hoffman - Director | Open-market purchase | Common Stock | 10,000 | $3.50 | $35K | |
| Michael B. Hoffman - Director | Open-market purchase | Common Stock | 15,000 | $2.11 | $32K | |
| Maria-Luisa Maccecchini - Officer | Open-market purchase | Common Stock | 97,561 | $2.05 | $200K | |
| Claudine Bruck - Director | Option exercise | Common Stock | 7,142 | $0.14 | $1,000 | |
| Claudine Bruck - Director | Option exercise | Option | 7,142 | $0.00 | - | |
| Michael B. Hoffman - Director | Open-market purchase | Common Stock | 975,610 | $2.05 | $2.00M | |
| Michael B. Hoffman - Director | Grant or award | Common Stock | 5,000 | $2.28 | $11K | |
| Michael B. Hoffman - Director | Grant or award | Common Stock | 5,000 | $2.29 | $11K | |
| Michael B. Hoffman - Director | Grant or award | Common Stock | 5,000 | $2.30 | $12K | |
| Michael B. Hoffman - Director | Grant or award | Common Stock | 6,717 | $2.60 | $17K | |
| Michael B. Hoffman - Director | Grant or award | Common Stock | 5,283 | $2.59 | $14K | |
| Michael B. Hoffman - Director | Grant or award | Common Stock | 5,545 | $2.58 | $14K | |
| Michael B. Hoffman - Director | Grant or award | Common Stock | 1,100 | $2.57 | $3K | |
| Michael B. Hoffman - Director | Grant or award | Common Stock | 25,000 | $2.80 | $70K | |
| Michael B. Hoffman - Director | Grant or award | Common Stock | 1 | $2.83 | $3 | |
| Michael B. Hoffman - Director | Grant or award | Common Stock | 5,000 | $2.43 | $12K |
ANVS insider trading FAQ
What is the latest insider trade for ANVS?
Annovis Bio, Inc. (ANVS) has filed no insider reports in the last 90 days. The most recent on record is dated 22 May 2026. The full record for ANVS runs to 12 Form 4 filings, the earliest from 29 May 2025. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ANVS stock?
No insider purchases of ANVS were filed in the last 90 days. 13 purchases are on record for this company.
How many insiders are selling ANVS stock?
No insider sales of ANVS were filed in the last 90 days.
Where can I see ANVS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ANVS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Michael B. Hoffman view on EDGAR
- - Michael B. Hoffman view on EDGAR
- - Michael B. Hoffman view on EDGAR
- - Michael B. Hoffman view on EDGAR
- - Michael B. Hoffman view on EDGAR
- - Maria-Luisa Maccecchini view on EDGAR
- - Claudine Bruck view on EDGAR
- - Michael B. Hoffman view on EDGAR
- - Michael B. Hoffman view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where ANVS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ANVS with a 7-day demo
- ANVS on your watchlist
- Every ANVS Form 4 filing on record
- Up to 3 months of ANVS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
